Stein Schalkwijk
6PUBLICATIONS
7CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Jan 20, 2026
Straight to Phase III: Model-Informed Approach Speeds Depemokimab Clinical Development in Interleukin-5-Driven Diseases.Chiara Zecchin, Stein Schalkwijk, Isabelle J Pouliquen
|Aug 20, 2021
Concentration-QT modelling in early clinical oncology settings: Simulation evaluation of performance.Gael Cantet, Alienor Berges, Rhianna O'Sullivan
|Jul 29, 2021
Clinical evaluation of the potential drug-drug interactions of savolitinib: Interaction with rifampicin, itraconazole, famotidine or midazolam.Song Ren, Karthick Vishwanathan, Mireille Cantarini
|Apr 27, 2021
Population pharmacokinetics and exposure-response of selumetinib and its N-desmethyl metabolite in pediatric patients with neurofibromatosis type 1 and inoperable plexiform neurofibromas.Stein Schalkwijk, Li Zhou, Sarit Cohen-Rabbie
|Mar 10, 2018
A Mechanism-Based Population Pharmacokinetic Analysis Assessing the Feasibility of Efavirenz Dose Reduction to 400 mg in Pregnant Women.Stein Schalkwijk, Rob Ter Heine, Angela C Colbers
|Jul 27, 2017
Prediction of Fetal Darunavir Exposure by Integrating Human Ex-Vivo Placental Transfer and Physiologically Based Pharmacokinetic Modeling.Stein Schalkwijk, Aaron O Buaben, Jolien J M Freriksen
Pageof 1
